145 Unraveling the Dyslipidemic Landscape in Moyamoya Disease: OxLDL as a Key Biomarker

View at publisher Summarise with VIRAT
Authors: Chaofan Zeng, Haoyuan Chen, Jizong Zhao, Qian Zhang
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Moyamoya disease (MMD) is a cerebrovascular disorder characterized by progressive intracranial arterial stenosis and fragile collateral formation. While genetic and hemodynamic factors are implicated, emerging evidence suggests dyslipidemia may contribute to its pathogenesis. However, comprehensive lipid profiling in MMD remains underexplored. METHODS: This prospective case-control study enrolled 222 MMD patients and 231 healthy controls (HCs). Comprehensive lipid profiling included standard lipids, apolipoproteins, oxidized LDL (oxLDL), and small dense LDL (sdLDL). Advanced statistical models (weighted quantile sum [WQS] and Bayesian kernel machine regression [BKMR]) were applied to evaluate individual and joint lipid effects on MMD risk. Angiographic staging and genetic polymorphisms (RNF213, APOE) were analyzed. RESULTS: MMD patients exhibited significantly elevated oxLDL (P

Fields of Study & Subjects

Moyamoya disease diagnosis and treatment Lipoproteins and Cardiovascular Health Kawasaki Disease and Coronary Complications

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
24–24
Publication date
26 March 2026
Language
EN